UA107716C2 - Терапевтическое средство с замедленным высвобождением на основе соединения 2-фенилтиазола для гипертонии и почечной дисфункции - Google Patents

Терапевтическое средство с замедленным высвобождением на основе соединения 2-фенилтиазола для гипертонии и почечной дисфункции

Info

Publication number
UA107716C2
UA107716C2 UAA201300872A UAA201300872A UA107716C2 UA 107716 C2 UA107716 C2 UA 107716C2 UA A201300872 A UAA201300872 A UA A201300872A UA A201300872 A UAA201300872 A UA A201300872A UA 107716 C2 UA107716 C2 UA 107716C2
Authority
UA
Ukraine
Prior art keywords
hypertension
blood pressure
high blood
renal dysfunction
normal high
Prior art date
Application number
UAA201300872A
Other languages
English (en)
Ukrainian (uk)
Inventor
Такасі Сіракура
Мідзухо Тамура
Йосімаса Такахасі
Іппей Кувахара
Original Assignee
Тейдзін Фарма Лімітед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45371556&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA107716(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Тейдзін Фарма Лімітед filed Critical Тейдзін Фарма Лімітед
Publication of UA107716C2 publication Critical patent/UA107716C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

В данном изобретении разработано терапевтическое или профилактическое средство для лечения гипертонии или обычно высокого артериального давления и почечной дисфункции. В изобретении разработана фармацевтическая композиция с замедленным высвобождением, содержащая в качестве активного компонента соединение 2-фенилтиазола, представленное следующей химической формулой (I) EMBED ISISServer , (I) или ее фармацевтически приемлемую соль.
UAA201300872A 2010-06-25 2011-06-24 Терапевтическое средство с замедленным высвобождением на основе соединения 2-фенилтиазола для гипертонии и почечной дисфункции UA107716C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2010145056 2010-06-25
PCT/JP2011/064569 WO2011162390A1 (ja) 2010-06-25 2011-06-24 徐放性高血圧および腎機能障害治療剤

Publications (1)

Publication Number Publication Date
UA107716C2 true UA107716C2 (ru) 2015-02-10

Family

ID=45371556

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201300872A UA107716C2 (ru) 2010-06-25 2011-06-24 Терапевтическое средство с замедленным высвобождением на основе соединения 2-фенилтиазола для гипертонии и почечной дисфункции

Country Status (25)

Country Link
US (1) US20130109726A1 (ru)
EP (1) EP2586442A4 (ru)
JP (1) JPWO2011162390A1 (ru)
KR (1) KR20130088755A (ru)
CN (1) CN102958521A (ru)
AR (1) AR082022A1 (ru)
AU (1) AU2011270133B2 (ru)
BR (1) BR112012032543A2 (ru)
CA (1) CA2803163A1 (ru)
CL (1) CL2012003661A1 (ru)
CO (1) CO6660504A2 (ru)
EC (1) ECSP12012352A (ru)
MA (1) MA34328B1 (ru)
MX (1) MX2012015040A (ru)
MY (1) MY160963A (ru)
NZ (1) NZ605516A (ru)
PE (1) PE20130241A1 (ru)
RU (1) RU2013103366A (ru)
SG (1) SG186798A1 (ru)
TN (1) TN2012000568A1 (ru)
TW (1) TW201215389A (ru)
UA (1) UA107716C2 (ru)
UY (1) UY33468A (ru)
WO (1) WO2011162390A1 (ru)
ZA (1) ZA201209388B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101872189B1 (ko) 2010-06-16 2018-06-29 다케다 파마슈티칼스 유에스에이, 인코포레이티드 크산틴 옥시도리덕타제 억제제 또는 크산틴 옥시다제 억제제의 신규한 조절 방출 제형
RU2013109380A (ru) 2010-09-10 2014-10-20 Такеда Фармасьютикалс Ю.С.А.,Инк. Способ сопутствующей терапии с применением теофиллина и фебуксостата
AR089812A1 (es) * 2012-01-27 2014-09-17 Teijin Pharma Ltd Agente terapeutico para la diabetes mellitus

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU645867B2 (en) 1990-11-30 1994-01-27 Teijin Pharma Limited 2-arylthiazole derivative and pharmaceutical composition containing the same
US6998404B2 (en) * 2001-08-08 2006-02-14 Genomed, Llc Treatment or prevention of acute renal failure
JP5242393B2 (ja) * 2005-08-03 2013-07-24 タケダ ファーマシューティカルズ ユー．エス．エー． インコーポレイティド 高血圧症の治療方法
CA2619744C (en) * 2005-08-18 2014-09-02 Teijin Pharma Limited Formulation having accurate dose-dividing function
KR20160031040A (ko) 2006-11-13 2016-03-21 다케다 파마슈티칼스 유에스에이, 인코포레이티드 크산틴 옥시도리덕타아제 억제제를 사용하여 신장 기능을 보존하는 방법
CN101658505A (zh) * 2009-09-29 2010-03-03 北京华禧联合科技发展有限公司 非布索坦的缓释制剂及其制备方法
KR101872189B1 (ko) * 2010-06-16 2018-06-29 다케다 파마슈티칼스 유에스에이, 인코포레이티드 크산틴 옥시도리덕타제 억제제 또는 크산틴 옥시다제 억제제의 신규한 조절 방출 제형

Also Published As

Publication number Publication date
ZA201209388B (en) 2013-08-28
NZ605516A (en) 2015-02-27
RU2013103366A (ru) 2014-07-27
UY33468A (es) 2012-01-31
WO2011162390A1 (ja) 2011-12-29
CN102958521A (zh) 2013-03-06
US20130109726A1 (en) 2013-05-02
AU2011270133B2 (en) 2014-03-20
MA34328B1 (fr) 2013-06-01
BR112012032543A2 (pt) 2016-11-22
KR20130088755A (ko) 2013-08-08
CO6660504A2 (es) 2013-04-30
PE20130241A1 (es) 2013-03-04
CL2012003661A1 (es) 2013-04-01
TN2012000568A1 (en) 2014-04-01
SG186798A1 (en) 2013-02-28
JPWO2011162390A1 (ja) 2013-08-22
TW201215389A (en) 2012-04-16
CA2803163A1 (en) 2011-12-29
MY160963A (en) 2017-03-31
ECSP12012352A (es) 2013-02-28
MX2012015040A (es) 2013-02-07
AR082022A1 (es) 2012-11-07
EP2586442A1 (en) 2013-05-01
EP2586442A4 (en) 2014-01-01
AU2011270133A1 (en) 2013-01-10

Similar Documents

Publication Publication Date Title
MX2020010151A (es) Analogos de piridazina 1,4-disustituida y metodos para el tratamiento de condiciones relacionadas con la deficiencia de smn.
TN2012000421A1 (en) Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents
WO2007143600A3 (en) Sheddase inhibitors combined with cd30-binding immunotherapeutics for the treatment of cd30 positive diseases
MX2015008975A (es) Analogos de tiadiazol y metodos para el tratamiento de afecciones relacionadas con deficiencia del gen de supervivencia de las neuronas motoras (smn).
UA97348C2 (en) HETEROCYCLIC NF-kB INHIBITORS
MX2013007336A (es) Compuestos de bi-heteroarilo como inhibidores de vps34.
UA105229C2 (ru) Фармацевтический состав
TN2013000257A1 (en) Immunosuppressant formulations
TN2012000458A1 (en) Uses of dgat1 inhibitors
MX2012008509A (es) Agente terapeutico o profilactic para enfermedades del tracto biliar.
MY163762A (en) Therapeutic agent for chronic renal failure
WO2007145863A3 (en) Sustained release formulation of naltrexone
JO3192B1 (ar) مركب بنزوثيازولون
EA201590474A1 (ru) ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ОСНОВЕ КОМПОЗИТНЫХ КАПСУЛ, ВКЛЮЧАЮЩИХ ИРБЕСАРТАН И ИНГИБИТОР ГМГ-КоА РЕДУКТАЗЫ
TN2012000568A1 (en) Sustained-release therapeutic agent for hypertension and renal dysfunction
MX2011013541A (es) Agente terapeutico para la hipertension o de la presion sanguinea normal elevada.
AU2012225365A8 (en) Peptide deformylase inhibitors
MX2008011842A (es) Procedimientos y composiciones para el tratamiento de insuficiencia cardiaca diastolica.
PH12015501696B1 (en) Prophylactic or therapeutic drug for constipation
MY143949A (en) An orally active thrombin inhibitor
TN2009000449A1 (en) Use of hdac inhibitors for the treatment of melanoma
TN2010000584A1 (en) Paediatric compositions for treating multiple scleoris
UA58748U (ru) Способ лечения рецидивирующей герпетической инфекции